BiotechTubeBiotechTube
Home/BioArctic AB/Christopher H. van der Kaay
CH

Christopher H. van der Kaay

Vice President, Investor Relations & Corporate Communications

BioArctic AB

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Diseases

BioArctic AB Pipeline

DrugIndicationPhase
Lecanemab (Leqembi®)Early Alzheimer's DiseaseApproved
BAN2802Alzheimer's DiseasePreclinical
Lecanemab SCAlzheimer's DiseasePhase 3
ABBV-0805Parkinson's DiseasePhase 1
BAN1202Parkinson's DiseasePreclinical

Leadership Team at BioArctic AB

GO
Gunilla Osswald
Chief Executive Officer
JI
Johan Ihre
Chief Financial Officer
EO
Erika Otterström-Lindblad
Chief Operating Officer
PG
Pär Gellerfors
Chief Scientific Officer
EW
Elin Winblad
Chief Medical Officer
EN
Eva Nise
Chief Human Resources Officer
ML
Mikael Lindstam
Chief Business Development Officer
MW
Mikael Ward
Chairman of the Board
MP
Mats Pettersson
Board Member
SL
Susanne Ljung
Board Member
View full BioArctic AB profile